Search Results for "R"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for R. Results 481 to 490 of 996 total matches.

Lifileucel (Amtagvi): A Cellular Therapy for Melanoma (online only)

   
The Medical Letter on Drugs and Therapeutics • Apr 29, 2024  (Issue 1701)
tumor tissue. Treatment-related mortality and prolonged severe cytopenias can occur. 1. R Seth et al ...
Lifileucel (Amtagvi – Iovance), a tumor-derived autologous T-cell immunotherapy, has received accelerated approval from the FDA for one-time treatment of adults with unresectable or metastatic melanoma previously treated with a programmed death receptor-1 (PD-1) inhibitor, and if BRAF V600 mutation-positive, a BRAF inhibitor with or without a mitogen-activated kinase (MEK) inhibitor. It is the first cellular therapy to be approved for use in solid tumors. Accelerated approval of lifileucel was based on objective response rates.
Med Lett Drugs Ther. 2024 Apr 29;66(1701):e77-8   doi:10.58347/tml.2024.1701h |  Show IntroductionHide Introduction

Acute Reactions to Drugs of Abuse

   
The Medical Letter on Drugs and Therapeutics • Mar 04, 2002  (Issue 1125)
of Medicine; F. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Elizabeth Stephens, M.D ...
Acute toxic reactions to drugs of abuse continue to be important problems. Some patients may have mixed intoxications with complex combinations of signs and symptoms.
Med Lett Drugs Ther. 2002 Mar 4;44(1125):21-4 |  Show IntroductionHide Introduction

Drugs for Psychotic Disorders

   
The Medical Letter on Drugs and Therapeutics • Dec 19, 2016  (Issue 1510)
Lett Drugs Ther 2015; 57:152. 18. R Emsley et al. Long-acting injectable antipsychotics in early ...
Oral antipsychotic drugs used for treatment of schizophrenia, schizoaffective disorder, delusional disorder, and other manifestations of psychosis or mania are listed in Table 1. Parenteral antipsychotic drugs used for treatment of these disorders are listed in Table 2.
Med Lett Drugs Ther. 2016 Dec 19;58(1510):160-4 |  Show IntroductionHide Introduction

Fluoxetine For Depression

   
The Medical Letter on Drugs and Therapeutics • Apr 22, 1988  (Issue 764)
; R Fontaine and G Chouinard, J Clin Psychopharmacol, 6:98, 1986). No data are available to indicate ...
Fluoxetine (Prozac - Dista), a phenylpropylamide, is the first serotonin-reuptake blocker introduced in the USA for treatment of . It is being promoted as causing fewer adverse effects than other antidepressants. Claims of greater safety and patient tolerability have often been made for new non-tricyclic antidepressants in recent years, but unpredicted adverse effects have emerged with widespread use, including priapism with trazodone (Desyrel - Medical Letter, 26:35, 1984) and fatal hemolytic anemia with nomifensine (Merital - Medical Letter, 27:73, 1985).
Med Lett Drugs Ther. 1988 Apr 22;30(764):45-7 |  Show IntroductionHide Introduction

Tretinoin for Photodamaged Skin

   
The Medical Letter on Drugs and Therapeutics • Mar 20, 1992  (Issue 866)
thickness increased more with the abrasive (R Marks et al, Br J Dermatol, 123:457, 1990). Another study ...
Tretinoin (tret' i noyn; all-trans-retinoic acid; Retin-A), a derivative of vitamin A, has been used for years for topical treatment of acne. More recently, it has also been used to improve the appearance of skin damaged by chronic exposure to the sun, although not approved for this indication by the US Food and Drug Administration.
Med Lett Drugs Ther. 1992 Mar 20;34(866):28-9 |  Show IntroductionHide Introduction

Paclitaxel (Taxol) for Ovarian Cancer

   
The Medical Letter on Drugs and Therapeutics • May 14, 1993  (Issue 896)
, but a semi-synthetic product (taxotere) prepared from the needles of European yews has shown some promise (R ...
Paclitaxel (Taxol - Bristol-Myers Squibb) is now available in the USA for treatment of metastatic ovarian cancer refractory to other drugs. The new drug is a natural product extracted in small amounts from the inner bark of the Western yew tree found mainly in the Pacific northwest (Taxus brevifolia). Efforts to synthesize the drug have been unsuccessful to date, but a semi-synthetic product (taxotere) prepared from the needles of European yews has shown some promise (R Pazdur et al, J Natl Cancer Inst, 89:1781, 1992), and a fungus (Taxomyces andreanae) growing on the Pacific yew was...
Med Lett Drugs Ther. 1993 May 14;35(896):39-40 |  Show IntroductionHide Introduction

Famciclovir for Herpes Zoster

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 1994  (Issue 934)
occurred more frequently with famciclovir than with placebo (R Saltzman et al, Antimicrob Agents Chemother ...
Famciclovir (Famvir - SmithKline Beecham) is now available in the USA for oral treatment of acute uncomplicated herpes zoster (shingles). The manufacturer claims that use of the drug reduces the duration of postherpetic neuralgia. Famciclovir is similar to acyclovir (Zovirax - Burroughs Wellcome), which has been the drug of choice for treatment of varicella-zoster and herpes simplex virus infections (Medical Letter, 36:27, 1994).
Med Lett Drugs Ther. 1994 Oct 28;36(934):97-8 |  Show IntroductionHide Introduction

Sirolimus (Rapamune) for Transplant Rejection

   
The Medical Letter on Drugs and Therapeutics • Feb 07, 2000  (Issue 1071)
. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Richard Kim, M.D., Vanderbilt ...
Sirolimus, whlch is structurally related to tacrolimus, has been approved by the FDA for prevention of acute renal transplant rejection. The manufacturer recommends that sirolimus be taken with cyclosporine and corticosteroids.
Med Lett Drugs Ther. 2000 Feb 7;42(1071):13-4 |  Show IntroductionHide Introduction

Bexarotene (Targretin) For Cutaneous T-cell Lymphoma

   
The Medical Letter on Drugs and Therapeutics • Apr 03, 2000  (Issue 1075)
Hospital, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D ...
Bexarotene, a retinoid analog, has been approved by the US Food and Drug Administration for oral treatment of dermatologic manifestations of refractory cutaneous T-cell lymphoma.
Med Lett Drugs Ther. 2000 Apr 3;42(1075):31-2 |  Show IntroductionHide Introduction

Colesevelam (Welchol) For Hypercholesterolemia

   
The Medical Letter on Drugs and Therapeutics • Oct 30, 2000  (Issue 1091)
., University Hospital, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D ...
Colesevelam hydrochloride (Welchol - Sankyo Pharma), a nonabsorbed hydrophilic polymer that binds bile acids, has been approved by the FDA for reduction of plasma LDL cholesterol in patients with primary hypercholesterolemia.
Med Lett Drugs Ther. 2000 Oct 30;42(1091):102-4 |  Show IntroductionHide Introduction